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Background: Acute interstitial pneumonia is a rare interstitial lung disease that rapidly progresses to respiratory
failure or death. Several studies showed that myofibroblast plays an important role in the evolution of diffuse
alveolar damage, which is the typical feature of acute interstitial pneumonia. However, no evidence exists whether
alveolar epithelial cells are an additional source of myofibroblasts via epithelial-mesenchymal transition in acute
interstitial pneumonia.
Case presentation: In this report, we present a case of acute interstitial pneumonia in a previously healthy
28-year-old non-smoking woman. Chest high-resolution computed tomography scan showed bilateral and diffusely
ground-glass opacification. The biopsy was performed on the fifth day of her hospitalization, and results showed
manifestation of acute exudative phase of diffuse alveolar damage characterized by hyaline membrane formation.
On the basis of the preliminary diagnosis of acute interstitial pneumonia, high-dose glucocorticoid was used.
However, this drug showed poor clinical response and could improve the patient’s symptoms only during the early
phase. The patient eventually died of respiratory dysfunction. Histological findings in autopsy were consistent with
the late form of acute interstitial pneumonia.
Conclusions: The results in this study revealed that alveolar epithelial cells underwent epithelial-mesenchymal
transition and may be an important origin of myofibroblasts in the progression of acute interstitial pneumonia.
Conducting research on the transformation of alveolar epithelial cells into myofibroblasts in the lung tissue of
patients with acute interstitial pneumonia may be beneficial for the treatment of this disease. However, to our
knowledge, no research has been conducted on this topic.
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Acute interstitial pneumonia (AIP), also known as
Hamman-Rich syndrome, is a fulminating interstitial
lung disease characterized by acute respiratory failure.
The clinical features presented by majority of patients are
described as a flulike prodrome including sore throat,
headache, cough, dyspnea, and often fever with abrupt
onset and short duration [1].* Correspondence: songxd71@163.com
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unless otherwise stated.The histological hallmark of AIP was defined as diffuse
alveolar damage (DAD), which is a nonspecific reaction
in the lung to many injurious agents. The pathologic
progress of DAD can be separated into three phases:
acute exudative phase, which is characterized by intersti-
tial edema, hyaline membrane, and acute interstitial in-
flammation accumulation [2]; proliferative phase, which
is characterized by interstitial thickening and the appear-
ance of granulation tissue in alveolar spaces [3]; and fi-
brotic phase, which is characterized by enlarged fibrotic
septa and laminated intra-alveolar fibrosis [4].
The primary focus of therapy is supportive care. How-
ever, the use of glucocorticoids and immunosuppressivehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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fatality ratio remains high (>60 percent) despite intensive
treatment and the majority of patients die within six
months of presentation [5]. Thus, the pathologic process
of the disease should be urgently explored, and a new
therapeutic target should be identified.
Epithelial-mesenchymal transition (EMT), defined by
the loss of epithelial characteristics and the acquisition of
a mesenchymal phenotype, is essential for the progress of
embryonic development [6]. Numerous studies revealed
that the abnormal activation of EMT programs plays an
important role in tissue fibrosis, cancer invasion, and me-
tastasis [7-9]. However, the emergence and importance of
EMT in lungs of patients with AIP remain unclear.
In this report, we present the case of a 28-year-old fe-
male diagnosed with AIP through histological and radio-
logical lung examinations. Pathological and ultrastructural
findings at open lung biopsy and autopsy showed that al-
veolar epithelial cells underwent EMT which may be
beneficial for early intervention of AIP.
Case presentation
A previously healthy 28-year-old non-smoking woman
was admitted to the hospital because of cough, mild dys-
pnoea, and fever of 38°C. The blood pressure, heart rate,
and respiration rate of the patient were 103.0/63.0 mmHg,
100 beats/min, and 25 beats/min, respectively. During
physical examination, she presented tachycardia, cyanosis,
and diffusely reduced breath sounds but no vesicular
murmur, crackles, or wheezing. Blood gas analysis revealed
the following findings: pH 7.47; pCO2, 40 mmHg; pO2,
53 mmHg; HCO3
-, 29.1 mmol/L; and Lac, 0.6 mmol/L.
These findings indicate hypoxemia. High-resolution com-
puted tomography (HRCT) of the chest revealed bilateral
diffuse airspace opacification (Figure 1A). Levofloxacin
was administered intravenously for 4 d. Her conditionFigure 1 Radiological findings of the patient. A, Chest High-resolution
opacification when the patient was hospitalized; B, Chest HRCT, taken on t
ground-glass opacification. C, the HRCT findings of the patient, who was tr
ground-glass attenuation.deteriorated with acute onset of dyspnoea and rapidly pro-
gressive respiratory failure, and the patient required intub-
ation and mechanical ventilation. Blood gas analysis
indicated hypoxemia; pH 7.19; pO2, 32 mmHg; and pCO2,
35 mmHg. HRCT revealed the deterioration of diffuse
ground-glass opacification (Figure 1B). Fiberoptic bron-
choscopy was performed on the same day after the patient
was transferred to an intensive care unit. The bronchial
tubes were normal with little sputum. Microbiologic in-
vestigations were negative. Transbronchial lung biopsies
were performed on the same lobe (left upper lobe) on the
fifth day of hospitalization. The first lung specimen exhib-
ited edema, hyaline membrane formation, and acute inter-
stitial inflammation, which all suggest an exudative phase
of AIP (Figure 2A). High doses of intravenous methylpred-
nisolone (500 mg for 3 d and 160 mg for 2 d) were admin-
istered based on presumptive diagnosis of interstitial lung
disease. After 5 d, HRCT revealed diffuse ground-glass at-
tenuation (Figure 1C). However, the patient still had acute
hypoxic respiratory failure and could not be extubated
after the procedure. Despite initiating intravenous with
normal dose of methylprednisolone (80 mg per day) and
high concentrations of oxygen, the patient remained intu-
bated for eight weeks. Chest X-ray analysis indicated that
her lung deteriorated did not improve even when high-
dose glucocorticoid was re-administered. Her oxygen sat-
uration was only 30% when the fraction of inspired oxygen
was 100%. The patient eventually expired after 62 d of
hospitalization. The patient underwent autopsy, and the
slides showed diffusely thickened alveolar septal intersti-
tium by hyaline membrane remnants, pulmonary inter-
stitial and alveolar edema, type II pneumocyte hyperplasia
(Figure 2B), and significant amount of myofibroblasts
(Figure 3). These results indicate organized DAD. Trans-
mission electron microscopy revealed that the epithelial
cells, which are characterized by their basement membranecomputed tomography (HRCT) showed bilateral diffuse airspace
he fourth hospital day, demonstrated the worsening of diffused
eated with high dose of methylprednisolone for 5 d, showed diffuse
Figure 2 Hematoxylin and eosin (H & E) stain. A, Lung biopsy revealed edema, hyaline membranes, and acute interstitial inflammation
representing the exudative phase of DAD. B, Lung autopsy showed interstitial and intra-alveolar fibroblast proliferation, which is the feature of
the fibrotic phase.
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bundles of filament in the cytoplasm (Figure 4). The
presence of filaments in these cells suggested the occur-
rence of EMT. We then determined the changes in
EMT-related proteins, such as surfactant associated pro-
tein (SPC), α-smooth muscle actin (α-SMA), and Snail.
(Santa Cruz Biotechnology Inc. Dallas, Texas, USA). The
results of the double immunostaining of the lungs
showed mesenchymal specific protein α-SMA in the al-
veolar epithelial cells (SPC-positive cells). The double
positive cells were evidently increased in the lung tissue
from the 62 d autopsy compared with that from the 5 d
biopsy (Figure 5). The zinc finger transcription factorFigure 3 Emergence of myofibroblasts in lung tissue. A, Immunohistoc
existed in the lung section from autopsy (62 d). B, Toluidine blue staining d
section from autopsy (62 d).Snail was evidently expressed in the lung tissue, espe-
cially in the lung tissue from the 62 d autopsy (Figure 6).
Conclusions
AIP is one of the six subtypes of major idiopathic inter-
stitial pneumonia according to the American Thoracic
Society/European Respiratory Society classification [10].
Given that many diseases could mimic AIP, multidiscip-
linary diagnosis, which requires a combination of clin-
ical, radiological, and pathological findings, is needed.
The case reported a patient with typical appearances of
AIP. Apart from supplemental oxygen and mechanical
ventilation, the patient received high-dose intravenoushemistry staining showed that an amount of α-SMA-positive cells
emonstrated a significant amount of fibroblastic foci in the lung
Figure 4 Ultrastructural findings of the lung tissue from the
patient. Ultrastructural finding on autopsy (62 d) of the lung
revealed bundles of actin microfilaments in the epithelial cells
characterized partly by basement membrane.
Li et al. BMC Pulmonary Medicine 2014, 14:67 Page 4 of 6
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prednisolone for several days. However, the treatment
could not contribute to the patient’s survival. The data
from this case confirmed the occurrence of EMT in AIP
and maybe beneficial for the treatment of this disease.Figure 5 Double positive cells for SPC and α-SMA existed in the hum
were stained with SPC (green) and α-SMA (red) antibodies followed by inc
was used to stain the nuclei (blue). The mean fluorescence intensity of α-S
Plus software and expressed in fluorescence units (FU) and bar graph repre
Yellow fluorescence represents fluorescence coexpression indicating that e
were counted respectively in each whole image and bar graph represents the
experiments (right). P-values were calculated using two-tailed Student’s t-testThe process of lung injury with subsequent develop-
ment of scar tissue in idiopathic pulmonary fibrosis has
been likened to an abnormal wound healing model. A
similar construct may be applied to AIP [11]. In theory,
intervention before the deposition of mature collagen
should allow the restoration of normal lung architecture.
The marked expansion of myofibroblast numbers within
the alveolar septa responds for the subsequent collagen
production in the proliferative and fibrotic AIP [12].
Consistent with this conclusion, we also detected an
amount of myofibroblast in the patient’s lung tissue.
This myofibroblast may be related to the AIP process.
Previous observations revealed that injured epithelial
cells could gradually lose their epithelial cell markers
and polarity, thus expressing mesenchymal markers and
acquiring single-cell motility [13], which was defined as
EMT. During EMT, cytoskeletal reprogramming estab-
lishes the presence of α-SMA stress fibers in epithelial
cells [14]. Through this transition, alveolar epithelial
cells serve as an importance source of myofibroblasts
during tissue injury response. Kalluri et al. [15] reported
that under inflammatory stress, 30% of myofibroblasts
can arise via EMT, whereas resident fibroblasts contrib-
ute only 23% in the kidney. Several articles reported thatan lung tissue. The lung sections from biopsy (5 d) and autopsy (62 d)
ubation with fluorescent dye-tagged secondary antibodies. Hoechst
MA in each whole image was automatically quantified by Image-Pro
sents the average value from three independent experiments (left).
pithelial cells underwent EMT. The α-SMA+SPC+ cells and SPC+ cells
average value (α-SMA+SPC+ cells/ SPC+ cells) from three independent
s. #, P < 0.05.
Figure 6 Detection of Snai1 expression in human lung tissue. The EMT transcription factor was detected by confocal immunofluorescence
microscopy. The mean fluorescence intensity of Snai1 in each whole image was automatically quantified by Image-Pro Plus software and
expressed in fluorescence units (FU). Bar graph represents the average value from three independent experiments. Increased expression of
Snai1 (green) was observed in the lung sections from biopsy (5 d) and autopsy (62 d). P-values were calculated using two-tailed Student’s
t-tests. #, P < 0.01.
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velopmental disorders, fibrotic tissue remodeling, and lung
cancer in humans [16-18]. Harada et al. [19] demonstrated
the presence of EMT in patients with usual interstitial
pneumonia pattern. However, Yamada et al. [20] obtained
conflicting results and did not detect double-positive
cells for E-cadherin, ICAM-1, LEA CD44v9, SP-A, α-
SMA, or vimentin in lung tissues from patients with idio-
pathic pulmonary fibrosis and nonspecific interstitial
pneumonia. Therefore, the evidence of myofibroblasts
originating from epithelial cells through EMT in intersti-
tial pneumonia remains controversial. Our ultrastructural
data supported the existence of EMT in the lung tissue of
patients with AIP. We also found that SPC and α-SMA,
which are markers for alveolar epithelial cells and myofi-
broblasts, respectively [16], coexisted in the patient’s sec-
tions. The EMT program in epithelial cells is identified to
be switched on by many transcription factors. For ex-
ample, Snail, a major transcription factor governing EMT
[21], could regulate the expression of genes related to
epithelial and mesenchymal phenotype [22]. We found
that the expression of Snail in the lung tissue of the pa-
tient was upregulated in the proliferative phase of AIP
compared with the exudative phase of AIP.In conclusion, the results of this study confirmed that
alveolar epithelial cells underwent EMT, which maybe
an important origin of myofibroblasts in the progression
of AIP. Although pathological manifestation may vary
from one case of AIP to another, our finding partly indi-
cated the possibility and importance of EMT in AIP and
provided a potential therapeutic method of preventing
EMT in AIP.
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